Onyx(美國(guó))

Onyx Pharmaceuticals

美國(guó)OnyxPharmaceuticals,Inc.www.onyx-pharm.com2009Onyx將以8.51億美元收購(gòu)抗癌藥開(kāi)發(fā)商ProteolixOnyxPharmaceuticals,Inc.isabiopharmaceuticalcompanycommittedtoimprovingthelivesofpeoplewithcancer.Ourapprovedproduct,Nexav ar®(sorafenib)tablets,isanovel,oralmultiplekinaseinhibitorthattargetsproteinsinvolvedinbothtumorcellproliferationandangiogenesis.Nexavarisapprovedinmorethan80countriesforthetreatmentofpatientswithunresectablelivercancerandinmorethan90countriesforthetreatmentofpatientswithadvancedkidneycancer.Aspartofabroadclinicaldevelopmentprogram,NexavarisalsobeingevaluatedinmultiplePhase3andPhase2trialsasasingleagentorcombinationtreatmentinawiderangeofcancers,includinglungcancer,thyroidcancer,breastcancer,colorectalcancer,ovariancancer,andasanadjuvanttherapyforlivercancerandkidneycancer.Nexavarisbeingdevelopedandmarketedincollab